Ainara Larrazabal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ainara Larrazabal has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andima Basterretxea
Bioprinting Laboratory, Regenerative Therapies, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain
2 shared publications - Elena Perez-Zabala
Bioprinting Laboratory, Regenerative Therapies, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain
2 shared publications - Isabel Andia
Regenerative Therapies Biocruces Bizkaia Health Research Institute, Cruces University Hospital Barakaldo Spain
2 shared publications - Arantza Perez-Valle
Regenerative Therapies, Bioprinting Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain
1 shared publication - Cristina Del Amo
Regenerative Therapies, Bioprinting Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain
1 shared publication - Eva Rubio-Azpeitia
Biocruces Health Research Institute, Cruces University Hospital, Barakaldo, Spain
1 shared publication
Latest Publications
- Open Access
- 17 January 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2) , 624
Wound Dressing Selection Is Critical to Enhance Platelet-Rich Fibrin Activities in Wound Care
The use of platelet-rich fibrin (PRF) is investigated in ulcer management because it provides a healing milieu rich in growth factors and cytokines. Although crucial, the relevance of secondary dressings is under-researched and no data support the use of any particular dressing in preference to another. We assessed the properties of different dressing categories, including alginates, hydrocolloids, foams, hydrofibers, films, meshes and gauzes, in terms of affinity for PRF, releasate management (retention/extrusion) and the kinetics of cytokine release as well as the influence of each combination product, [PRF + dressing], on dermal cell behaviour, aiming to provide useful information for choosing the most adequate dressing for each particular patient. Active dressings including alginates, hydrofibers, foams and hydrocolloids blend with PRF, creating a diverse combination of products with different performances. Alginate and hydrofiber showed the highest affinity but moderate retention of releasate, without interfering with cell functions. Instead, the foam sequestered the releasate and hindered the release of growth factors, thereby compromising cell activities. Film and mesh presented very poor releasate retention and performed similarly to PRF by itself. Affinity index and releasate management explained 79% of platelet-derived growth factor (PDGF-BB) concentration variability, p < 0.001. Cell proliferation depended on the ability of the combination product to retain/release supernatant, PDGF-BB concentration and cell adhesion R2 = 0.91, p = 0.014.
- 17 January 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2) , 624
Open AccessWound Dressing Selection Is Critical to Enhance Platelet-Rich Fibrin Activities in Wound Care
The use of platelet-rich fibrin (PRF) is investigated in ulcer management because it provides a healing milieu rich in growth factors and cytokines. Although crucial, the relevance of secondary dressings is under-researched and no data support the use of any particular dressing in preference to another. We assessed the properties of different dressing categories, including alginates, hydrocolloids, foams, hydrofibers, films, meshes and gauzes, in terms of affinity for PRF, releasate management (retention/extrusion) and the kinetics of cytokine release as well as the influence of each combination product, [PRF + dressing], on dermal cell behaviour, aiming to provide useful information for choosing the most adequate dressing for each particular patient. Active dressings including alginates, hydrofibers, foams and hydrocolloids blend with PRF, creating a diverse combination of products with different performances. Alginate and hydrofiber showed the highest affinity but moderate retention of releasate, without interfering with cell functions. Instead, the foam sequestered the releasate and hindered the release of growth factors, thereby compromising cell activities. Film and mesh presented very poor releasate retention and performed similarly to PRF by itself. Affinity index and releasate management explained 79% of platelet-derived growth factor (PDGF-BB) concentration variability, p < 0.001. Cell proliferation depended on the ability of the combination product to retain/release supernatant, PDGF-BB concentration and cell adhesion R2 = 0.91, p = 0.014.
- 1 May 2016
- Published by Elsevier in Journal of Tissue Viability
- Vol. 25 (2) , 157-163
Biological approach for the management of non-healing diabetic foot ulcers
- 1 May 2016
- Published by Elsevier in Journal of Tissue Viability
- Vol. 25 (2) , 157-163
Biological approach for the management of non-healing diabetic foot ulcers